Categories: News

Deep Blue Med Spa Lead PA Melissa Colletti-White is One of the First Providers Nationwide to Offer JUVÉDERM® VOLUX™ XC

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

The First and Only HA Filler FDA-approved for Jawline Definition, Brought to Market by Allergan Aesthetics, the Makers of Botox ® Cosmetic

Melissa Colletti-White, PA-C

Melissa Colletti-White, PA-C holds the new VOLUX ™ XCMelissa Colletti-White, PA-C holds the new VOLUX ™ XC
Melissa Colletti-White, PA-C holds the new VOLUX ™ XC

Garden City, NY, Nov. 15, 2022 (GLOBE NEWSWIRE) — Garden City, NY- (November 15, 2022) Deep Blue Med Spa, a celebrated medical spa overseen by Long Island Plastic Surgical Group, the largest, longest running plastic surgery group in the United States, is proud to be among the first practices nationwide to offer VOLUX ™ XC. 

Currently, this product is only available for use by Allergan Medical Institute Trainers. Melissa Colletti-White, PA-C and lead clinician at Deep Blue, is one of only two trainers eligible to now treat patients with this filler on Long Island. 

VOLUX ™ XC is the latest innovation from JUVÉDERM®— one of the world’s most premier filler collections. It is indicated for improvement of jawline contour in adults over the age of 21 with jowling and/ or moderate to severe loss of jawline definition. 

“As Medical Director of Deep Blue Med Spa, I am proud of our reputation for consistently offering patients the latest and greatest in aesthetic innovations,” began Dr. Laurence T. Glickman. “It is only fitting that Melissa would be amongst the first to utilize this product, as her skill as both an injector and trainer are exceptional.”   


About Deep Blue Med Spa 

At Deep Blue Med Spa, we are committed to offering innovative aesthetic services customized for individual patient needs. Our team of licensed medical aestheticians, nurse practitioners, and physician assistants treat patients throughout Long Island and Manhattan. Deep Blue Med Spa is an extension of and overseen by Long Island Plastic Surgical Group (LIPSG). Beginning in 2023, which will mark the 75th year of LIPSG, the practice will be rebranded to New York Plastic Surgical Group. This name change reflects the growth and expansion of the practice beyond Long Island.

Attachment

CONTACT: Jeanine DiGennaro
tel. (516) 629-3835
email: jdigennaro@lipsg.com

Staff

Recent Posts

KNoW Biological Receives FDA Breakthrough Device Designation

Atlanta-based firm to begin clinical trial on advanced warning seizure monitor ATLANTA, May 13, 2025…

60 minutes ago

Wincomm Wins Best Choice Award at COMPUTEX 2025 for AI-Driven Surgical Panel PC

HSINCHU, May 13, 2025 /PRNewswire/ -- Wincomm, a global leader in medical-grade computing solutions, has…

60 minutes ago

Fangzhou CEO Honored at 2025 VBEF Conference as Company Showcases AI Medical Innovations

SUZHOU, China, May 13, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader…

60 minutes ago

For Labbit, Semaphore Solutions Recognized in the Gartner® Market Guide for Laboratory Information Management Systems

VICTORIA, BC, May 13, 2025 /PRNewswire/ - Semaphore Solutions, a leading provider of laboratory informatics…

60 minutes ago

GI Innovation and GI Biome Advance to the Semi-finals of XPRIZE Healthspan with Anti-Aging Potential of GI-102 and GIB-7 Combination Therapy

GI Innovation and GI Biome have been selected as a Top 40 semi-finalist in the XPRIZE Healthspan competition among…

7 hours ago

Tyra Biosciences to Participate at Upcoming Investor Conferences

CARLSBAD, Calif., May 12, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology…

13 hours ago